The Korea Food and Drug Administration has taken a recall action due to crystallization occurring in children's fever syrup.

COMPANY / Reporter Kim SangJin / 2024-05-27 03:45:38
Children's fever reducer which was recalled due to crystallization. (Photo: Korea Food and Drug Administration)

 

[Alpha Biz= Reporter Kim Sangjin] According to the Korea Food and Drug Administration, some syrup-type children's fever relievers sold in pharmacies have been found to contain crystallization, prompting a recall order.


On the 24th, according to the administration, certain products of "NaeRin Syrup (active ingredient: acetaminophen)" produced by TELCON RF PHARMACEUTICAL and sold by Kwangdong Pharmaceutical have exhibited crystallization in the liquid, leading to ongoing recall procedures by the distributors.

The products subject to recall have the manufacturing number 23001 and an expiration date of February 26, 2025.

An official from the administration stated, "We are currently investigating the cause of the crystallization."

 

Alphabiz Reporter Kim SangJin(letyou@alphabiz.co.kr)

어플

주요기사

Kolmar Korea Certified as Year’s First ‘Reshoring’ Company; To Invest 100 Billion KRW in Smart Factory Expansion
Court Dismisses Additional Lawsuits by Shareholders Over "Invossa" Controversy, Ruling in Favor of Kolon
Nvidia Delays China H200 Chip Exports Amid Ongoing Talks With U.S. Government
Naver Issues Formal Apology Over Exposure of Celebrities’ and Politicians’ Past "Ji-sik-iN" Posts
CJ Logistics Designated as Unfaithful Disclosure Corporation Over Delayed Notice of $2.7B Libyan Counterclaim
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

SNS